Target intelligence / Profile preview

Motor neuron and pancreas homeobox protein 1 (MNX1)

Target
MNX1
Molecular classification
Transcription factor, Homeobox protein
01

Overview

Motor neuron and pancreas homeobox protein 1 (MNX1) is a transcription factor in the homeobox protein family, which contains a homeodomain critical for DNA binding and regulation of gene expression. MNX1 is essential for embryonic development, especially for the formation and differentiation of motor neurons and pancreatic beta cells. Mutations or loss of MNX1 function cause congenital malformations such as Currarino syndrome, affecting the sacrum and hindgut. Aberrant MNX1 expression is strongly implicated in oncogenesis, including aggressive forms of bladder cancer and infant acute myeloid leukemia, mainly through regulation of cell proliferation and cell cycle genes such as CCNE1 and CCNE2. MNX1 serves as a prognostic marker in certain cancers and as a genetic marker in developmental disorders. There are currently no approved drugs that directly modulate MNX1, and therapeutic targeting is challenged by its essential role in normal development.

Other names
Homeobox HB9HLXB9HB9HOXHB9SCRA1MNR2motor neuron and pancreas homeobox 1homeobox protein HB9motor neuron and pancreas homeobox protein 1
02

Mechanism of action

Not directly targeted by drugs in clinical use, but aberrant expression leads to pathological states; mechanism involves transcriptional regulation of cell cycle genes (e.g., CCNE1, CCNE2) and developmental genes

03

Biological functions

Regulation of embryonic developmentDifferentiation and formation of motor neuronsDifferentiation and development of pancreatic beta cellsRegulation of the cell cycleRegulation of proliferation in cancer cells
04

Disease associations

Congenital malformations (Currarino syndrome)Cancer (Bladder cancer, infant acute myeloid leukemia, hepatocellular carcinoma, prostate cancer, breast carcinoma, insulinoma)
05

Safety considerations

Lack of specificity as a target due to widespread developmental functionsPotential risk of disrupting normal embryogenesis and tissue development if inhibited
06

Biomarkers

Prognostic biomarker in bladder cancer (higher expression correlated with poorer prognosis)Diagnostic marker for Currarino syndrome and related malformations

Beyond the preview

Go deeper on Motor neuron and pancreas homeobox protein 1 (MNX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Motor neuron and pancreas homeobox protein 1 (MNX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call